UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000029764 |
|---|---|
| Receipt number | R000034007 |
| Scientific Title | Observational study to clarify the pathology of malignant tumors using cancer clinical sequence data and to evaluate the clinical value of cancer clinical sequence |
| Date of disclosure of the study information | 2017/11/01 |
| Last modified on | 2017/11/01 09:00:07 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Observational study to clarify the pathology of malignant tumors using cancer clinical sequence data and to evaluate the clinical value of cancer clinical sequence
Acronym
Observational study for evaluation of basic and clinical value of cancer clinical sequence
Scientific Title
Observational study to clarify the pathology of malignant tumors using cancer clinical sequence data and to evaluate the clinical value of cancer clinical sequence
Scientific Title:Acronym
Observational study for evaluation of basic and clinical value of cancer clinical sequence
Region
| Japan |
Condition
Condition
Patients who underwent cancer clinical sequence examination
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
To evaluate and clarify the effect of cancer clinical sequence on treatment and prognosis of cancer patients
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Prognosis of patients who underwent cancer clinical sequence
Key secondary outcomes
Whether the cancer clinical sequence had influence on patient's treatment choice
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
subjects who obtained document agreement with the free will of the subjects themselves or substitute persons with sufficient understanding, after receiving sufficient explanation for participation in this research
Key exclusion criteria
Patients who are judged inappropriate as the subject by the research director
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Shunsuke Kato |
Organization
Juntendo Univ Hospital
Division name
Dept Oncology
Zip code
Address
3-1-3 Hongo Bunkyo Tokyo, Japan
TEL
03-3813-3111
katoshun@juntendo.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Shunsuke Kato |
Organization
Juntendo Univ Hospital
Division name
Dept Oncology
Zip code
Address
3-1-3 Hongo Bunkyo Tokyo, Japan
TEL
03-3813-3111
Homepage URL
katoshun@juntendo.ac.jp
Sponsor or person
Institute
Juntendo Univ Hospital
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
YES
Study ID_1
2016044
Org. issuing International ID_1
Juntendo Univ Hospital
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2017 | Year | 11 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 11 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
It is a collaborative research with the Yokohama City University hospital
Management information
Registered date
| 2017 | Year | 10 | Month | 30 | Day |
Last modified on
| 2017 | Year | 11 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034007
